Recent studies suggest that the radiological infiltrative feature (r-IF) of renal tumors is strongly correlated with poor oncologic outcomes in locally advanced renal cell carcinoma (RCC). This study investigated the prognostic impact of r-IF of primary renal tumors in metastatic RCC (mRCC) in comparison with International Metastatic RCC Database Consortium (IMDC) risk model.
We retrospectively analyzed 91 patients with previously untreated mRCC. Dynamic computed tomography of the primary renal tumor was reviewed to assess r-IF, defined as a focally/extensively ill-defined tumor interface with normal renal parenchyma.
The median age was 67 years, and 69 patients (76%) were men. Prior nephrectomy was performed in 47 patients (52%). The median size of the primary renal tumor was 6.7 cm, and 50 patients (55%) presented with cT3-4 stage. Overall, 25 (28%)/52 (57%)/14 (15%) patients were classified into IMDC favorable/intermediate/poor-risk groups, respectively. An image review identified r-IFs in the primary renal tumor in 40 patients (44%). The incidences of r-IFs were 28%/46%/64% in IMDC favorable/intermediate/poor-risk groups, respectively. During a median follow-up of 2.6 years, 31 patients (34%) died of RCC. On multivariable analysis, r-IF and IMDC intermediate-poor risks were independently associated with poor cancer-specific survival (CSS). Two-year CSS were 64%/87% in patients with/without r-IF, respectively. C-index was improved from 0.73 to 0.81 by adding r-IF to the IMDC risk factors.
R-IF of the primary renal tumor was an independent risk factor for poor CSS in patients with mRCC, which may improve the prognostic accuracy when combined with the IMDC risk model.
International journal of urology : official journal of the Japanese Urological Association. 2023 Jun 20 [Epub ahead of print]
Yoshitomo Yamaguchi, Hajime Tanaka, Koichiro Kimura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Akihiro Hirakawa, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii
Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan., Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan., Department of Clinical Biostatistics, Tokyo Medical and Dental University, Tokyo, Japan., Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.